Platelet-activating factor stimulates multiple signaling pathways in cultured rat mesangial cells
- PMID: 1331121
- DOI: 10.1002/jcp.1041530204
Platelet-activating factor stimulates multiple signaling pathways in cultured rat mesangial cells
Abstract
We have previously reported that platelet-activating factor (PAF) elevates cytosolic free calcium concentration ([Ca2+]i) in fura-2-loaded glomerular mesangial cells. To confirm that this increase in [Ca2+]i is a result of receptor-mediated activation of phospholipase C, we investigated hydrolysis of phosphatidylinositol-4,5-bisphosphate (PtdIns-4,5-P2) in PAF-treated mesangial cells. PAF (10(-7) M) stimulated a rapid and transient formation of inositol trisphosphate. In concomitant experiments, PAF stimulated a biphasic accumulation of 3H-arachidonate-labeled 1,2-diacylglycerol (DAG). The secondary elevation in DAG was coincident with a rise in 3H-phosphorylcholine (PC) and 3H-phosphorylethanolamine (PE) suggesting that PAF stimulates delayed phospholipase activities which hydrolyze alternate phospholipids besides the polyphosphoinositides. This PAF-stimulated elevation in 3H-water soluble phosphorylbases was seen at 5 min but not at 15 sec suggesting that the initial rise in DAG as well as the initial elevation in [Ca2+]i are due primarily to PtdIns-4,5-P2 hydrolysis. PAF also stimulated PGE2 as well as 3H-arachidonic acid and 3H-lyso phosphatidylcholine (PtdCho) formation. We suggest that arachidonate released specifically from PtdCho via phospholipase A2 is a source of this PAF-elevated PGE2. It has been postulated that anti-inflammatory prostaglandins may antagonize the contractile and proinflammatory effects of PAF via activation of adenylate cyclase. Surprisingly, exogenous PAF reduced basal and receptor-mediated cAMP concentration indicating that PAF-stimulated transmembrane signaling pathways may oppose receptor-mediated activation of adenylyl cyclase. We have taken advantage of the different sensitivities of phospholipases A2 and C(s) to PMA, EGTA, and pertussis toxin to dissociate phospholipase A2 and C activities. Acute PMA-treatment enhanced PAF-stimulated PGE2 formation, reduced PAF-induced elevations in [Ca2+]i and had no effect upon PAF-stimulated 3H-PE. We have also demonstrated that phospholipase A2, but not PtdIns-specific phospholipase C, was sensitive to external calcium concentration. The role of a GTP-binding protein to couple PAF-receptors to the PtdIns-specific phospholipase C was confirmed as GTP gamma S synergistically elevated PAF-stimulated inositol phosphate formation. We also demonstrated that pertussis toxin ADP-ribosylates a single protein of an apparent 42 kD mass and that PAF pretreatment reduced subsequent ADP-ribosylation in a time-dependent manner. However, pertussis toxin had no effect upon phospholipase C-generated water soluble phosphorylbases or inositol phosphates. In contrast, PAF-stimulated phospholipase A2 and PAF-inhibited adenylyl cyclase activities were sensitive to pertussis toxin.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Platelet-activating factor stimulates phosphatidic acid formation in cultured rat mesangial cells: roles of phospholipase D, diglyceride kinase, and de novo phospholipid synthesis.J Cell Physiol. 1993 Aug;156(2):317-25. doi: 10.1002/jcp.1041560214. J Cell Physiol. 1993. PMID: 8393878
-
Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.Mol Pharmacol. 1992 Feb;41(2):281-9. Mol Pharmacol. 1992. PMID: 1311408
-
Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils.J Immunol. 1989 Aug 15;143(4):1295-302. J Immunol. 1989. PMID: 2545786
-
Activation of the phospholipase/cyclooxygenase cascade in the rabbit cornea by platelet-activating factor is challenged by PAF receptor antagonists.J Ocul Pharmacol Ther. 1995 Fall;11(3):329-37. doi: 10.1089/jop.1995.11.329. J Ocul Pharmacol Ther. 1995. PMID: 8590265 Review.
-
Inositol phospholipid turnover in PAF transmembrane signalling.Lipids. 1991 Dec;26(12):1028-33. doi: 10.1007/BF02536496. Lipids. 1991. PMID: 1668102 Review.
Cited by
-
Cyclic guanosine monophosphate is the mediator of platelet-activating factor inhibition on transport by the mouse kidney thick ascending limb.J Clin Invest. 1994 Sep;94(3):1156-62. doi: 10.1172/JCI117431. J Clin Invest. 1994. PMID: 7521885 Free PMC article.
-
Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease.Diabetes Metab Syndr Obes. 2022 Jul 8;15:2003-2030. doi: 10.2147/DMSO.S367483. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 35837578 Free PMC article. Review.
-
The role of platelet-activating factor in mesangial pathophysiology.Am J Pathol. 2015 Apr;185(4):888-96. doi: 10.1016/j.ajpath.2014.11.025. Epub 2015 Feb 2. Am J Pathol. 2015. PMID: 25655028 Free PMC article. Review.
-
Characterization of acetyl-CoA: lyso-PAF acetyltransferase of human mesangial cells.Mediators Inflamm. 2005 Oct 24;2005(5):263-72. doi: 10.1155/MI.2005.263. Mediators Inflamm. 2005. PMID: 16258193 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous